XML 49 R39.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Other income (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2018
Schedule of Other Income |
|  | Three months ended June 30, |  |  | Six months ended June 30, |
|  | 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
|  | (U.S. $ in millions) |
Gain (loss) on divestitures, net of divestitures related costs (1) |  | $ | (10 | ) |  |  | — |  |  | $ | 83 |  |  |  | — |
Section 8 and similar payments (2) |  |  | 95 |  |  |  | 8 |  |  |  | 194 |  |  |  | 83 |
Gain on sale of assets |  |  | 1 |  |  |  | — |  |  |  | 9 |  |  |  | — |
Other, net |  |  | 10 |  |  |  | 16 |  |  |  | 13 |  |  |  | 13 |
Total other income |  | $ | 96 |  |  | $ | 24 |  |  | $ | 299 |  |  | $ | 96 |
(1) | Gain related to the divestment of the women’s health business in 2018. See note 3.
(2) | Section 8 of the Patented Medicines (Notice of Compliance) Regulation relates to recoveries of lost revenue related to patent infringement proceedings in Canada.

X
- Definition Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 + Details
Name: | us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration